What’s New in Photon Counting CT?

June 30, 2026 · 8 articles · 8 research themes · covering June 23, 2026 – June 30, 2026

Overview

Across this week’s set of papers, a dominant theme is how photon-counting CT (PCD/PCCT) is moving from “better images” toward more quantitative, task-specific information—whether that means improved material discrimination, more accurate physical property estimation, or functional imaging with targeted contrast agents. Physics and methods papers highlight fundamental performance limits (e.g., proton stopping power ratio/range estimation) and show how design choices such as higher-dimensional material decomposition can reduce uncertainty. Complementing this, algorithmic work proposes practical ways to derive effective physical density from clinical PC-CT data, supporting the broader goal of turning spectral measurements into quantitative biomarkers.

Several studies then translate these capabilities into clinical domains. Cardiovascular reviews and acute coronary syndrome research emphasize that spectral/advanced CT can improve assessment beyond stenosis detection—supporting plaque phenotyping and risk stratification. In parallel, non-cardiac applications showcase where PCCT’s spectral separation may matter most: dual-agent musculoskeletal arthrography (iodine + gadolinium + calcium separation), and agent-based functional lung imaging that combines xenon ventilation with gadolinium signal using color K-edge approaches. Finally, clinical perspective/review articles argue for integrating advanced CT into real diagnostic pathways—highlighting limitations of conventional temporal bone CT in “imaging-negative” conductive hearing loss and positioning PCCT as a future upgrade for emergency urinary tract imaging workflows.

---

Photon-Counting CT (PCD/PCCT) Fundamentals & Physics

Optimal dimensionality and fundamental limits of proton stopping power estimation with photon-counting CT material decomposition.

This 2026 physics study evaluated fundamental limits and optimal dimensionality for proton stopping power ratio (SPR) and range estimation using photon-counting CT (PCCT) with material decomposition. The key finding was that increasing the dimensionality of material decomposition can improve SPR/range estimation accuracy in PCCT, but there are fundamental constraints that bound achievable performance for proton therapy planning. Scientifically, it informs how to design PCCT-based material decomposition strategies to reduce range uncertainty and treatment margins.

Larsson K, Näsmark T, Andersson J et al. · Physics in medicine and biology · (2026) · View on PubMed ↗ · Free PDF ↗

---

Photon-Counting CT for Quantitative Material/Property Mapping

An algorithm to calculate physical density of biomedical objects having 3 ≤ Zeff ≤ 20: an application study using clinical photon-counting computed tomography equipment.

This 2026 algorithm development study proposed a method to calculate effective physical density (ρeff) for biomedical objects with effective atomic number (Zeff) between 3 and 20 using clinical photon-counting CT equipment. The key finding was that ρeff can be derived by fitting interaction cross sections to measured linear attenuation coefficients obtained from virtual monochromatic images, with Zeff analyzed in advance and fed back into the density estimation. Scientifically, it advances quantitative PC-CT reconstruction/analysis enabling more accurate material/physical property mapping from clinical photon-counting data.

Hayashi H, Nishigami R, Asahara T et al. · Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine · (2026) · View on PubMed ↗

---

Spectral/Agent-Based Functional Imaging (Ventilation-Perfusion, K-edge, Dual Agents)

Simultaneous pulmonary ventilation and perfusion imaging using spectral photon counting CT with xenon and gadolinium-based agents in combination with color K-edge imaging.

This 2026 animal feasibility study investigated simultaneous pulmonary ventilation and perfusion imaging using spectral photon-counting CT (SPCCT) with xenon gas and a gadolinium-based ultrasmall rigid platform (USRP) plus color K-edge imaging in five New Zealand white rabbits. The key finding was that color K-edge-enabled spectral photon counting can separate and quantify gadolinium signal while enabling xenon-based ventilation assessment for combined ventilation-perfusion evaluation. Clinically, it supports a pathway toward noninvasive, agent-based functional lung imaging that could improve assessment of ventilation-perfusion mismatch.

Robert A, Poletto S, Erhard K et al. · Diagnostic and interventional imaging · (2026) · View on PubMed ↗ · Free PDF ↗

---

Photon-Counting CT in Cardiovascular Imaging (Reviews)

Photon-counting detector CT in cardiovascular imaging: technical advances, clinical applications, and future perspectives.

This 2026 review studied photon-counting detector CT (PCD-CT) across cardiovascular imaging by synthesizing evidence from PubMed, Web of Science, and Embase (Jan 2015–Mar 2025) for applications such as coronary artery disease and congenital heart disease. The key finding was that PCD-CT offers technical advantages (spectral information and improved material discrimination) that can translate into improved cardiovascular assessment, while current limitations and future directions remain important for clinical adoption. Scientifically, it consolidates evidence to guide researchers and clinical imagers on where PCD-CT may improve diagnosis/prognosis and where performance constraints still limit use.

Hong Z, Yao B, Wu H · The international journal of cardiovascular imaging · (2026) · View on PubMed ↗

---

CCTA & High-Risk Plaque Assessment in Acute Coronary Syndrome

Diagnostic and Prognostic Value of Coronary Computed Tomography Angiography and High-Risk Plaque Assessment in Acute Coronary Syndrome.

This 2026 review studied the diagnostic and prognostic value of coronary computed tomography angiography (CCTA) and high-risk plaque assessment in patients presenting with acute coronary syndrome (ACS). The key finding was that beyond detecting coronary stenosis, CCTA can characterize plaque composition and identify high-risk plaque features that may improve patient selection for invasive coronary angiography and risk stratification. Clinically, it supports using CCTA not only for anatomy but also for plaque phenotyping to better guide ACS management.

Miceli AL, Iroulart JM, Domenech P et al. · Current problems in cardiology · (2026) · View on PubMed ↗

---

Clinical Integration of Advanced CT in Non-Cardiac Specialties (Emergency/Workflow)

Acute Non-Traumatic Urinary Tract Emergencies: The Central Role of CT Imaging and the Emerging Role of Photon-Counting CT.

This 2026 review studied acute non-traumatic urinary tract emergencies and emphasized the central role of CT imaging while highlighting the emerging role of photon-counting CT (PCCT). The key finding was that CT (and MRI/ultrasound where appropriate) provides characteristic imaging patterns for obstructive, infectious, vascular, hemorrhagic conditions, and urinary leaks, and that PCCT may further enhance imaging capabilities as it becomes available. Clinically, it supports optimized emergency imaging pathways and positions PCCT as a future upgrade for improved diagnostic performance in urinary tract emergencies.

Scaglione M, Masala SA, Di Grezia G et al. · Canadian Association of Radiologists journal = Journal l’Association canadienne des radiologistes · (2026) · View on PubMed ↗ · Free PDF ↗

---

Photon-Counting CT in Musculoskeletal Imaging (Arthrography)

A pilot study: dual-contrast arthrography using photon-counting detector computed tomography with gadolinium and iodine contrasts.

This 2026 pilot study developed dual-contrast arthrography using photon-counting detector CT (PCD-CT) with gadolinium and iodine, using a material decomposition approach to separate and quantify iodine, gadolinium, and calcium. The key finding was that spectral imaging across energy bins spanning the iodine and gadolinium K-edges enabled simultaneous separation/quantification that is difficult with conventional CT/MRI when both agents are co-administered. Clinically, it suggests improved characterization of arthrographic contrast components for musculoskeletal evaluation where dual-agent information is needed.

Deng AX, Day J, Masella O et al. · Physics in medicine and biology · (2026) · View on PubMed ↗ · Free PDF ↗

---

Advanced Imaging for Otologic/Conductive Hearing Loss (Imaging-Negative Scenarios)

Conductive hearing loss and normal CT: a clinical perspective.

This clinical perspective reviewed literature and presented illustrative cases linking audiology with photon-counting detector CT in patients with conductive hearing loss but normal temporal bone CT findings. The key finding was that although conductive hearing loss is often assumed to have a corresponding temporal bone CT abnormality (e.g., otosclerosis), some pathophysiologic causes may be missed or not visualized on CT, leading to “imaging-negative” conductive hearing loss scenarios. Clinically, it emphasizes the need to integrate audiologic testing with advanced CT approaches and to recognize limitations of temporal bone CT when planning diagnostic workups.

Rao D, Raymond MJ, Breen JT et al. · Neuroradiology · (2026) · View on PubMed ↗

---

---

Generated automatically on June 30, 2026. Covers PubMed articles published June 23, 2026 – June 30, 2026. Summaries are AI-generated; always consult the original publication for clinical or research decisions.